Registration for NCI Gynecologic Cancer Steering Committee 2011 Ovarian Cancer Clinical Trials Planning Meeting has CLOSED.

NCI Gynecologic Cancer Steering Committee
2011 Ovarian Cancer Clinical Trials Planning Meeting

October 28–29, 2011

The goals of this meeting are to:

Develop a research agenda to address the development and validation of diagnostic strategies for molecular subtypes of epithelial ovarian carcinomas to include:

  • Biomarkers that are needed for critical pathways,
  • Biomarkers that are in development but need clinical grade validation, and
  • Biomarkers that are CLIA approved and ready for use in clinical trials.

Develop a research agenda for phase II and III evaluation of agents that target molecularly defined pathways to include:

  • Novel combinations and combinations with standard chemotherapy in epithelial ovarian carcinoma,
  • Agents that show preclinical promise, agents that are in early-phase trials, and
  • Agents/combinations ready for phase III trials.

Based on input from this meeting, a consensus will be reached on the most important clinical trials to conduct and a strategy for implementationthe GCSC Steering Committee will develop plans for implementation of the translational research required for the goals listed above. The intent is to prepare a list of actual trials that could be implemented over the next 3 – 5 years in 2012-2013 that could be developed.


NCI logo NIH logo DHHS logo